|
|
 |
|
|
|
|
Sleep apnea, sleep-disordered breathing, and intermittent
hypoxia have been identified and linked in latest research to
almost all major fatal medical conditions, from heart attack,
stroke, diabetes, COPD cancer, and major depressive disorders.
Current main-stream treatment options are unsatisfactory, and
the entire world is looking for a better or best solution.
This market is one of the most explosive and largely untapped
markets.
SleepApneaUSA.net, founded by Dr. Jin Zhou, relied upon
the latest research and clinically developed ZHT - Zhou's
Hypoxicology Therapy to discover a possible cure for sleep apnea
and provide an alternative care to those who can't tolerate
CPAP,"sleeping mask". |
|
|
|
|
|
|
We are looking for
visionary investors, strategic partners, business alliance and
concerned healthcare providers to advance our goals, to find and
provide with possible cure for sleep apnea, and its related
major fatal medical conditions.
This web site is
mainly for visionary investors, strategic business partners and
concerned healthcare providers. |
|
|
|
|
       
SleepApneaUSA.net
for Strategic Partners
Sleep Review (sleepreviewmag.com):
(2006-08-10)
Edison Health Innovations
Celebrates One-Year Anniversary of No-Mask, No-Surgery Therapy for Sleep
Apnea and Hypoxemia
|
Sleep Center
Partners |
 |
Clinical Research
Partners |
|
Educational
Seminars |
 |
 |
 |
If you operate or
manage sleep care centers, and find more diagnosed sleep
apnea patients who can never comply with or tolerate CPAP than
those who can, and maybe more than 70% of your tested
patient population are suffering every night hopelessly , and
would like to integrate or incorporate ZHT into your center to
save these patients, please contact Dr. Jin Zhou
 |
If you think
ZHT might be benefitial or important after reviewing the
information on this website, and interested in further clinical
exploration of ZHT in clinical research, please contact Dr. Jin
Zhou for further information.
|
We are currently offering ZHT
seminars to Chiropractic profession through "Edison
Innovations, Inc." at ZHTdoc.com
If you are interested in ZHT
Seminars for other professions, please comtact Dr. Jin Zhou.
|
|
|
SleepApneaUSA.net
for Strategic Partners
We are looking for visionary investors, strategic partners, business
alliance and concerned healthcare providers to advance our goals, to
find and provide with possible cure for sleep apnea, and its related
major fatal medical conditions.
We are in very early stage of clinical, research and business
adventure in this one of the most explosive and largely untapped
markets of the decade.
We would like to hear and see innovating ideas or proposals
from visionary investors and
from business and financial
partners or strategic alliances.
This web site is mainly for visionary investors, strategic
business partners and concerned healthcare providers.
About Dr. Jin Zhou & SleepApneaUSA.net
Our Mission
SleepApneaUSA.net, founded by Dr. Jin Zhou, relied
upon the latest research and clinically developed ZHT - Zhou's
Hypoxicology Therapy to discover a possible cure for sleep apnea and
provide an alternative care to those who can't tolerate
CPAP,"sleeping mask".
Company Profile
SleepApneaUSA.net, founded by Dr.
Jin Zhou, is a new business entity with clinically develop ZHT, and
current offering teaching and clinical research on sleep apnea and
sleep disordered breathing, chronic intermittent hypoxia related
illness and diseases.
We have presently planned to
explore further education of healthcare providers on sleep apnea,
and our ZHT programs, and also the possiblities for ZHT to be
integrading into current sleep care centers.
We also are planning to expand our ZHT clinical
research, with other healthcare professionals participation, into
many other major fatal medical conditions.
We are looking for visionary investors, strategic partners, business
alliance and concerned healthcare providers to advance our goals, to
find and provide with possible cure for sleep apnea, and its related
major fatal medical conditions.
The Market — Sleep apnea, sleep-disordered breathing, and
intermittent hypoxia have been identified and linked in latest
research to almost all major fatal medical conditions, from heart
attack, stroke, diabetes, COPD cancer, and major depressive
disorders.
Sleep apnea is a serious, potentially
life-threatening condition. It is a breathing disorder characterized
by repeated collapse of the upper airway during sleep, with
consequent cessation of breathing. Virtually all sleep apnea
patients have a history of loud snoring. They may also unknowingly
experience frequent arousals during the night, resulting in chronic
daytime sleepiness or fatigue. Sleep apnea appears
to be as common as some better known diseases. It is estimated that
4 percent of middle-aged men and 2 percent of middle-aged women meet
minimal criteria for sleep apnea syndrome.1 This compares to a 4.5
percent prevalence of asthma in middle-aged adults.2 Sleep apnea is
more prevalent among the obese, in males, and in older individuals.3
There also seems to be a higher prevalence of sleep apnea in the
hypertensive population. As increasing in public
awareness of sleep apnea and access and availability of sleep
testing, the number of people suffering from sleep disordered
breathing is growing faster than we can imagine, and it is estimated
more than 50% of this population will fail in compliance of CPAP
therapy or can't tolerate CPAP at all, thus the market and
population for effective but alternative therapy is bigger than
those under standard CPAP or surgical programs.
This market is one of the most explosive and largely untapped
markets.
The Problem — Current main-stream treatment options are
unsatisfactory, and the entire world is looking for a better or best
solution.
Snoring Costs Over $88 Billion in Lost
Productivity, Health Care Costs
Insurance Journal -
June 8, 2006
"Patients who suffer from snoring and sleep apnea also may
be suffering from depression and anxiety, and could have trouble
concentrating at work, according to a new study. The result -- a
cost to the U.S. economy of more than $88 billion in lost
productivity and health care costs."
CPAP
Merely Palliative in Obstructive Sleep Apnea
Dec 2005
[Medscape
(subscription)]
"NEW YORK (Reuters Health) Dec 21 - Treating
obstructive sleep apnea (OSA) with nasal continuous positive
airway pressure (CPAP) "is not a solution to the problem,"
researchers report in the December issue of the Annals of
Neurology. The real problem is the underlying neurological lesions
that cause disordered breathing and the solution, they say, is
prevention of progression of OSA....
Summing up, he added that it is important to
know the size and extent of the underlying neurological lesion
before surgery. It is also "important to realize that nasal CPAP
is not a complete solution and that non-compliance is a major
problem... surgery may be a better solution."
Is obstructive sleep apnea syndrome a
neurological disorder? A continuous positive airway pressure
follow-up study.
Ann Neurol. 2005 Dec;58(6):880-7.
PMID: 16240364 [PubMed - in process]
Guilleminault C, Huang YS, Kirisoglu C, Chan
A.
Obesity, High Blood Pressure Impacting Many U.S.
Adults Ages 55-64
(Press Release- Dec 8, 2005)
CDC Press
"Half of Americans aged 55-64
have high blood pressure – a major risk factor for heart disease
and stroke – and two in five are obese, according to Health,
United States, 2005, the government’s annual report to the
President and Congress on the health of all Americans. The
report was prepared by the Centers for Disease Control and
Prevention’s (CDC) National Center for Health Statistics from
data gathered by state and federal health agencies and through
ongoing national surveys."
UAB Study Finds Link Between Sleep
Apnea and High Blood Pressure
(Press Releases from
UAB)
11/16/2006
"Ubunama
and colleagues with the UAB Hypertension Program found that the
severity of sleep apnea is directly related to endothelial changes,......Sleep
apnea is very under-diagnosed, according to Ubunama, particularly
among patients with high blood pressure, and doctors rarely ask
about their patients’ sleep habits. However, in UAB hypertension
clinics, researchers have found the prevalence of sleep apnea in the
population of resistant hypertension patients,
specifically those who continue to experience uncontrolled high
blood pressure on three or more medications, is approximately 85
percent."
More couples sleeping in double beds, survey says
AZ Central.com, AZ - Dec 21,
2005
"Thus the blooming of sleep-study clinics.
According to the American Academy of Sleep Medicine, there are
now more than 800 accredited centers in the United States."
Waking up to sleep problems
- NorthJersey.com, NJ
"The search for deep,
uninterrupted, refreshing sleep has become a national obsession.
It's driving everything from the development of new prescription
sleeping pills to extensive bed makeovers in hotel chains."
Poway-based maker of sleep apnea pumps
expects to continue growth trend
(UNION-TRIBUNE,
signonsandiego.com) December 30,
2005
"Twenty years later, sleep specialists estimate
that 20 percent of adults
have sleep apnea – and Farrell thinks it is closer to 30 percent.
That means at least 18
million to 20 million people in the United States suffer
from just that one sleep disorder. About 7 percent of those cases
are moderate to severe. And only
4 million have been
diagnosed, Farrell said.
.........In fiscal 2005, which ended June 30, sales jumped 25
percent to $426 million, while net income grew 13 percent to $64.8
million, or $1.82 a share"
As stated above, due to poor compliance of CPAP
programs, a huge population of people with even known diagnosis of
obstructive sleep apnea (OSA) or central sleep apnea (CSA) is left
with no choices but suffering hopelessly. ZHT-
Zhou's Hypoxicolgy Therapy: Maximally establishing or opening Upper
Airway (Vocal Cord, Entire Trachea), maximizing respiration through
maximizing, optimizing and rematch in respiratory ventilation and
perfusion through body’s own physiological functions - upper airway
defense reflexes, such as swallowing and cough augmentation.
ZHT is an non-surgical, non-pharmaceutical and
manual therapy that can be used to benefit most clinical conditions.
Unlike other therapies currently
used for sleep apnea, ZHT (Zhou's hypoxicology Therapy)
identifies the root causes of sleep apnea, employs human
natural power, human systemic defense reflexes,
volitional resuscitations to eliminate and relieve not
only sleep apnea but also many other intermittent
hypoxia related health problems. Based currently published
research and ZHT clinical observations,
ZHT may have potential
to provide therapeutic values for diabetes, cancers, Alzheimer's
disease, Amyotrophic lateral sclerosis (ALS) and many more sleep
disordered breathing (SDB) and chronic intermittent hypoxia
related major illness and diseases. |
|
